Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes

Diabetologia

Volumn 48, Issue 12, 2005, Pages 2615-2621

  Perseghin, G ^a,b,c   Lattuada, G ^a   De Cobelli, F ^b   Esposito, A ^b   Costantino, F ^a   Canu, T ^b   Scifo, P ^b   De Taddeo, F ^b   Maffi, P ^b   Secchi, A ^b,d   Del Maschio, A ^b,d   Luzi, L ^a,b,c,e  

^a Section of Nutrition/Metabolism   (Italy)

^b IRCCS   (Italy)

^c Centre 'Physical Exercise for Health and Wellness'   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Ectopic fat; Insulin resistance; Intrahepatic fat content; Lipid oxidation; Magnetic resonance spectroscopy

Indexed keywords

FAT; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FAT CONTENT; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; LIPID STORAGE; MALE; MEDICAL ASSESSMENT; METABOLIC CLEARANCE RATE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RESPIRATORY QUOTIENT;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; ENERGY METABOLISM; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OXIDATION-REDUCTION;

EID: 28444437414     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-0014-5     Document Type: Article

References (30)

1. McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770
2. 1H NMR spectroscopy study. Diabetologia 42:113-116
3. 13C NMR spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
4. Perseghin G, Lattuada G, Danna M et al. (2003) Insulin resistance, intramyocellular lipid content and plasma adiponectin concentrations in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285:E1174-E1181
5. Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850
6. Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity an normal men. J Clin Endocrinol Metab 87:3023-3028
7. Wohl P, Wohl P, Girman P, Pelikanova T (2004) Inflexibility of energy substrate oxidation in type 1 diabetic patients. Metabolism 53:655-659
8. Raguso CA, Coggan AR, Gastaldelli A, Sidossis LS, Bastyr EJ III, Wolfe RR (1995) Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes 44: 1066-1074
9. Tuominen JA, Ebeling P, Vuorinen-Markkola H, Koivisto VA (1997) Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion. Diabet Med 14:301-308
10. Baecke JAH, Burema J, Frijters JER (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942
11. 3H-glucose infusion. Diabetologia 33:603-610
12. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat by using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495
13. Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-431
14. Perseghin G, Scifo P, Danna M et al. (2002) Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab 283:E556-E564
15. Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212-1216
16. Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H (1987) Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:834-840
17. Adkins-Marshall B, Pagliassotti MJ, Asher JR et al. (1992) Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am J Physiol Endocrinol Metab 262:E679-E686
18. De Fronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319
19. Lager I, Lönnroth P, Von Schenck H, Smith U (1983) Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287:1661-1664
20. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906-E916
21. Pietilainen KH, Rissanen A, Kaprio J et al. (2005) Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288:E768-E774
22. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycaemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603-608
23. McGarry JD, Foster DW (1977) Hormonal control of ketogenesis. Biochemical considerations. Arch Intern Med 137:495-501
24. Luzi L, Castellino P, Simonson DC, Petrides AS, DeFronzo RA (1990) Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes 39:38-48
25. Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3:340-351
26. Bugianesi E, Gastaldelli A, Vanni E et al. (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634-642
27. 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783-787
28. Bischof MG, Krssak M, Krebs M et al. (2001) Effects of short-term improvement of insulin treatment and glycaemia on hepatic glycogen metabolism in type 1 diabetes. Diabetes 50:392-398
29. Bischof MG, Bernroider E, Krssak M et al. (2002) Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycaemia. Diabetes 51:49-54
30. Roden M, Perseghin G, Petersen KF et al. (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642-648